HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduction of increased serum neutrophil chemotactic activity following effective hyposensitization in house dust mite allergy.

Abstract
Changes in the level of serum neutrophil chemotactic activity (S-NCA) were investigated in 20 subjects with allergic rhinitis, with or without asthma, undergoing clinically effective hyposensitization to house dust mite with Pharmalgen Dermatophagoides pteronyssinus. Two control groups were studied: 28 subjects with allergic rhinitis, with or without asthma, receiving placebo injections for 1 yr in a double-blind controlled trial with Pharmalgen D. pteronyssinus (from whom the actively treated group in this study were recruited), and eight non-atopic asymptomatic controls. S-NCA and serum IgE specific to D. pteronyssinus were measured in the subjects before, during (3-6 months) and 12 months after treatment, and once in the non-atopic controls. The mean S-NCA was significantly higher (0.01 greater than P greater than 0.001) in subjects before treatment (mean +/- s.e. = 63.8 +/- 3.6 arbitrary units of migration (AUM] compared with the non-atopic controls (48.5 +/- 3.7 AUM), but had fallen to normal levels after 6 months (46.8 +/- 4.0 AUM) and 12 months treatment (45.2 +/- 3.8 AUM). The levels of S-NCA in the placebo treated group were significantly higher than normal at the start of treatment (69.2 +/- 4.1) and remained raised throughout the 12 months treatment. In the actively treated group, the level of S-NCA had fallen in 18 out of 19 subjects after 12 months immunotherapy, and was unaltered in one. Mean levels of D. pteronyssinus IgE rose during the first 6 months and declined to initial levels by the end of the treatment.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsS M McHugh, P W Ewan
JournalClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (Clin Exp Allergy) Vol. 19 Issue 3 Pg. 327-34 (May 1989) ISSN: 0954-7894 [Print] England
PMID2660970 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chemotactic Factors
  • Dust
  • Interleukin-8
  • Immunoglobulin E
Topics
  • Adult
  • Animals
  • Chemotactic Factors (analysis)
  • Desensitization, Immunologic
  • Double-Blind Method
  • Dust
  • Female
  • Humans
  • Immunoglobulin E (analysis)
  • Immunotherapy
  • Injections
  • Interleukin-8
  • Male
  • Mites (immunology)
  • Rhinitis, Allergic, Perennial (blood, therapy)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: